National Institute of Allergy and Infectious Diseases Research Addressing Biodefense and Emerging and Re-emerging Infectious Diseases. Testimony before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations.
Anthony S. Fauci, M.D., NIAID Director
Dr. Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2019 is an estimated $5.5 billion.
Dr. Fauci has advised five Presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
NIAID Director, Dr. Anthony Fauci.
Credit: NIAID
Profiles, Awards, and Honors
Publications and Articles
December 1, 2018
NIH Statement on World AIDS Day
NIH Statement on World AIDS Day
Dr. Fauci in the News
Congressional Testimony
U.S. Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies: Review of the FY2019 Budget Request for the National Institutes of Health.
Videocast of Congressional Testimony from May 17, 2018
Laboratory of Immunoregulation
Dr. Fauci also is the long-time chief of the Laboratory of Immunoregulation (LIR). He has made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He helped pioneer the field of human immunoregulation by making important basic scientific observations that underpin the current understanding of the regulation of the human immune response.